Get the Stockscreener App
6.80
0.29%
-0.02
Pre-market:
6.93
0.13
+1.91%
Wave Life Sciences Ltd stock is traded at $6.80, with a volume of 1.24M.
It is down -0.29% in the last 24 hours and down -30.33% over the past month.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
See More
Previous Close:
$6.82
Open:
$6.89
24h Volume:
1.24M
Relative Volume:
0.71
Market Cap:
$1.08B
Revenue:
$93.95M
Net Income/Loss:
$-129.87M
P/E Ratio:
-7.5556
EPS:
-0.9
Net Cash Flow:
$-202.88M
1W Performance:
-7.98%
1M Performance:
-30.33%
6M Performance:
-33.14%
1Y Performance:
+19.09%
1-Day Range:
$6.755
$7.02
1-Week Range:
$6.755
$7.3554
52-Week Range:
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences Ltd
Sector
Industry
Phone
617-949-2900
Address
7 STRAITS VIEW, SINGAPORE
Compare WVE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
6.80 | 1.09B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Initiated | Canaccord Genuity | Buy |
| Jul-28-25 | Initiated | Oppenheimer | Outperform |
| Jul-16-25 | Initiated | Citigroup | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-25 | Initiated | Wedbush | Outperform |
| Feb-25-25 | Initiated | Jefferies | Buy |
| Oct-16-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-27-24 | Resumed | JP Morgan | Overweight |
| Sep-19-24 | Initiated | B. Riley Securities | Buy |
| Sep-09-24 | Initiated | JP Morgan | Overweight |
| May-15-24 | Initiated | Wells Fargo | Overweight |
| Dec-19-23 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-05-23 | Initiated | Raymond James | Outperform |
| May-24-23 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-20 | Resumed | H.C. Wainwright | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-31-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-01-19 | Initiated | Guggenheim | Buy |
| Jul-15-19 | Initiated | Cowen | Market Perform |
| Apr-17-19 | Reiterated | H.C. Wainwright | Buy |
| Aug-07-18 | Initiated | Stifel | Buy |
| Jul-23-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Feb-15-17 | Initiated | H.C. Wainwright | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | JMP Securities | Mkt Outperform |
| Dec-07-15 | Initiated | Jefferies | Buy |
| Dec-07-15 | Initiated | Leerink Partners | Outperform |
| Dec-07-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Wave Life Sciences Ltd Stock (WVE) Latest News
Wave Life Sciences’s SWOT analysis: RNA editing stock faces fierce competition - Investing.com
Aug Big Picture: Does Wave Life Sciences Ltd stock have upside surprise potential2025 Investor Takeaways & Precise Trade Entry Recommendations - خودرو بانک
Should I invest in Wave Life Sciences Ltd before earningsJuly 2025 PreEarnings & High Return Stock Watch Alerts - خودرو بانک
Aug Reactions: Is Wave Life Sciences Ltd. forming a double bottom2025 Market Overview & Weekly High Return Stock Forecasts - خودرو بانک
Risk Recap: Can Wave Life Sciences Ltd beat the S P 5002025 Buyback Activity & Free Fast Gain Swing Trade Alerts - خودرو بانک
Aug Patterns: Should I invest in Wave Life Sciences Ltd before earningsJuly 2025 Spike Watch & Low Volatility Stock Suggestions - خودرو بانک
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely - simplywall.st
Some Wave Life Sciences Ltd. (NASDAQ:WVE) Shareholders Look For Exit As Shares Take 29% Pounding - 富途牛牛
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 3.5%What's Next? - MarketBeat
Wave Life Sciences is Now Oversold (WVE) - Nasdaq
Polar Asset Management Partners Inc. Reduces Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
FY2027 EPS Forecast for WAVE Life Sciences Lifted by Analyst - MarketBeat
Trexquant Investment LP Trims Stake in WAVE Life Sciences Ltd. $WVE - MarketBeat
Wave Life Sciences (WVE) Sees Promising Results From RestorAATion-2 Study - simplywall.st
Invesco Ltd. Increases Stock Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences' (WVE) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Is Wave Life Sciences Ltd. the Top Chart Pick This WeekMarket Sentiment Review & Fast Momentum Stock Entry Tips - beatles.ru
Published on: 2025-09-08 19:37:33 - beatles.ru
Trendlines Converge — Decision Point for Wave Life Sciences Ltd.July 2025 Earnings & Expert Approved Trade Ideas - beatles.ru
What is the dividend yield of Wave Life Sciences Ltd.Weekly Market Summary & Growth Focused Entry Reports - beatles.ru
WAVE Life Sciences Ltd. $WVE Holdings Decreased by Jump Financial LLC - MarketBeat
Wave Life Sciences (NASDAQ:WVE) Pulls Back 14% This Week, but Still Delivers Shareholders Strong 37% CAGR Over 3 Years - 富途牛牛
Short interest data insights for Wave Life Sciences Ltd.Weekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Risk adjusted return profile for Wave Life Sciences Ltd. analyzedWeekly Stock Recap & High Accuracy Trade Alerts - Newser
Published on: 2025-09-05 14:47:35 - Newser
Predicting Wave Life Sciences Ltd. trend using moving averages2025 Market Overview & Fast Moving Stock Trade Plans - Newser
B. Riley’s Strategic Acquisition of Wave Life Sciences: Capitalizing on Biotech Market Inefficiencies - AInvest
Using data tools to time your Wave Life Sciences Ltd. exitPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser
Relative strength of Wave Life Sciences Ltd. in sector analysisJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Wave Life Sciences Ltd. technicalsJuly 2025 Retail & Daily Stock Trend Reports - Newser
What indicators show strength in Wave Life Sciences Ltd.July 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Should you hold or exit Wave Life Sciences Ltd. nowDay Trade & AI Enhanced Execution Alerts - Newser
What’s the analyst consensus on Wave Life Sciences Ltd.Bond Market & Real-Time Volume Analysis Alerts - خودرو بانک
What is Wave Life Sciences Ltd.’s market position2025 Valuation Update & Weekly High Conviction Ideas - خودرو بانک
Wave Life Sciences Ltd. shares fall 1.19% intraday after a special call presentation. - AInvest
What does recent volatility data suggest for Wave Life Sciences Ltd.Market Performance Summary & Proven Capital Preservation Tips - Newser
WVE: Wells Fargo Lowers Price Target to $18, Maintains Overweigh - GuruFocus
Will Wave Life Sciences Ltd. rebound enough to break evenProfit Target & Free High Return Stock Watch Alerts - Newser
Wave Life Sciences stock price target lowered to $16 at Jones Trading - Investing.com Canada
Momentum divergence signals in Wave Life Sciences Ltd. chartWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Wave Life Sciences stock price target lowered to $16 at Jones Trading By Investing.com - Investing.com Nigeria
Why Wave Life Sciences Ltd. is moving todayQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
WAVE Life Sciences stock maintains Outperform rating at Raymond James - Investing.com India
When is the best time to exit Wave Life Sciences Ltd.2025 Biggest Moves & Verified Entry Point Detection - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryWeekly Profit Analysis & Stock Portfolio Risk Management - Newser
Wave’s RNA editor gains proof of concept but not top positioning in AATD - biocentury.com
Will earnings trigger a reversal in Wave Life Sciences Ltd.Weekly Trade Report & Community Consensus Picks - Newser
WAVE Life Sciences stock maintains Outperform rating at Raymond James By Investing.com - Investing.com Australia
Wave Life says data are positive but stock wavers - BioWorld MedTech
Leerink Partners raises WAVE Life Sciences stock price target to $26 on AATD data - Investing.com
Assessing Wave Life Sciences' (WVE) RNA Editing Pipeline: Is the Stock Undervalued Amid Clinical Progress and Financial Challenges? - AInvest
Wave Life Sciences Ltd Stock (WVE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):